Skip to content
Search

Latest Stories

Synnovis cyber attack: NHS patient data leaked, services impacted

Synnovis cyber attack: NHS patient data leaked, services impacted
The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber attack causes major disruption across southeast London

On June 3, Synnovis, a pathology laboratory serving several NHS organisations in South East London, was targeted by a ransomware attack.

This cyber incident has disrupted vital blood testing services, crucial for a range of medical treatments, and raised significant concerns over data security.


NHS England confirmed that a cybercriminal group, Qilin, published data online, claiming it was stolen from Synnovis.

The National Crime Agency (NCA) and the National Cyber Security Centre (NCSC) are currently working to authenticate the data and understand its contents.

A helpline has been established to address patient concerns, and NHS England urges patients to attend their appointments unless otherwise directed.

The attack has rendered some of the NHS’s blood testing systems inoperable, causing substantial disruption to medical services in South East London.

In a statement, the NHS said: "Unprocessed samples were made safe by Synnovis and stored in their labs.

"However, due to the time that has now lapsed, some of these samples are no longer suitable for analysis and will need to be discarded."

Synnovis is working with the NHS Trusts and GP practices to determine which samples are affected and the process for informing patients.

While urgent and emergency services remain functional, including A&E and maternity departments, there may be delays in blood testing services.

Over 3,000 hospital and GP appointments have been affected.

According to a BBC report, the cybercriminal gang published nearly 400GB of sensitive data on the darknet.

This includes patient names, dates of birth, NHS numbers, and descriptions of blood tests.

Ciaran Martin, a cyber security expert and former head of the NCSC, described this attack as “one of the most significant and harmful cyber attacks ever in the UK.”

He told the BBC, “Cybercriminals go where the money is, and unfortunately, the money is in attacking the healthcare sector,” referencing a reported $22 million ransom paid by United Health Group earlier this year.

Previosuly, Qilin claimed they targeted Synnovis to punish the UK for not assisting in a conflict.

Martin dismissed this as "absolute garbage," emphasising that their motives were "entirely financial."

The gang, thought to be based in Russia, stated they could not disclose their exact location for security reasons.

Additionally, they have stolen data from other healthcare organisations, schools, companies, and councils globally.

NHS England’s Response

NHS England continues to collaborate with Synnovis, law enforcement, and cyber security experts to investigate the breach.

They advise individuals to remain vigilant against phishing scams and report suspicious activity to Action Fraud or the phishing reporting service.

NHSE assured patients that any updates regarding the data breach and its impact will be promptly shared on their website.

Patients are encouraged to continue using NHS services as normal, though there may be some rescheduling of tests and appointments.

The NHS will keep the public informed as more details emerge from the ongoing investigation.

Call for action: For further information, patients are advised to contact the incident helpline at 0345 8778967.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less